Journal article
Patient-Important Outcomes in Registered Diabetes Trials
Abstract
CONTEXT: Concerns about the safety and efficacy of diabetes interventions persist, in part because randomized clinical trials (RCTs) have not measured their effect on patient-important outcomes, ie, death and quality of life (morbidity, pain, function).
OBJECTIVE: To systematically determine the extent to which ongoing and future RCTs in diabetes will ascertain patient-important outcomes.
Authors
Gandhi GY; Murad MH; Fujiyoshi A; Mullan RJ; Flynn DN; Elamin MB; Swiglo BA; Isley WL; Guyatt GH; Montori VM
Journal
JAMA, Vol. 299, No. 21, pp. 2543–2549
Publisher
American Medical Association (AMA)
Publication Date
June 4, 2008
DOI
10.1001/jama.299.21.2543
ISSN
0098-7484